About this episode
According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop a new drug is over $1 billion; and testing can take over 10 years.
Noam Solomon is on a mission to change this. His company, Immunai, is using artificial intelligence to create an atlas of the human immune system.
This week on How I Built This Lab, Guy talks with Noam about how Immunai’s immune system mapping is accelerating the development of new personalized drug therapies. Plus, Noam shares how Immunai’s culture of ‘not knowing’ drives scientific innovation.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Get every episode summarized
Each time How I Built This with Guy Raz publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from How I Built This with Guy Raz
Room & Board: John Gabbert. A Broken Deal, a Family Rift, and the Birth of a Fur...
How I Built This with Guy Raz
Advice Line with Jonah Peretti of Buzzfeed
How I Built This with Guy Raz
Beautycounter: Gregg Renfrew. She Built Beautycounter to $1B… Then Got Fired Fro...
How I Built This with Guy Raz
Advice Line with David Neeleman of JetBlue
How I Built This with Guy Raz